Parameters | Total (n = 157) | Recurrence | p value | |
---|---|---|---|---|
Yes (n = 38) | No (n = 119) | |||
Age | ||||
Median (range) | 72 (42–96) | 76 (42–96) | 70 (42–92) | 0.004 |
Sex | ||||
Male/Female | 111/46 | 30/8 | 81/38 | 0.226 |
Location | ||||
Upper/Middle/Lower/extending in 2 or 3 regions | 32/23/91/11 | 6/4/23/5 | 26/19/68/6 | 0.798 |
Surgery | ||||
DG/TG/others | 104/50/3 | 24/13/1 | 80/37/2 | 0.692 |
Lymph node dissection | ||||
D1/D1+/D2 | 13/68/76 | 3/14/21 | 10/54/55 | 0.732 |
Synchronous multiple GCs | ||||
Yes/No | 17/140 | 4/34 | 13/106 | 1.000 |
Macroscopic type | ||||
0/1/2/3/4/5 | 78/10/25/17/17/10 | 3/4/11/7/10/3 | 75/6/14/10/7/7 | < 0.001 |
Histology | ||||
pap tub1/tub2/muc/por sig nec | 41/33/1/82 | 6/5/1/26 | 35/28/0/56 | 0.167 |
Depth of tumor invasion | ||||
pT1/pT2/pT3/pT4 | 78/15/42/22 | 3/3/15/17 | 75/12/27/5 | < 0.001 |
Cancer stromal volume | ||||
med /int/sci/not described | 5/72/38/42 | 0/18/19/1 | 5/54/19/41 | 0.027 |
Tumor infiltration pattern | ||||
INFa/INFb/INFc/not described | 4/70/54/29 | 1/16/21/0 | 3/54/33/29 | 0.220 |
VI grade | ||||
v0/v1/v2/v3 | 65/54/24/14 | 1/16/10/11 | 64/38/14/3 | < 0.001 |
Lymphatic invasion | ||||
Yes/No | 82/75 | 35/3 | 47/72 | < 0.001 |
Nodal metastasis | ||||
pN0/pN1/pN2/pN3 | 91/20/19/27 | 4/8/9/17 | 87/12/10/10 | < 0.001 |
Resection margin status | ||||
R0/R1/R2 | 149/7/1 | 32/5/1 | 117/2/0 | 0.001 |
pTNM stage | ||||
I/II/III | 82/34/41 | 3/10/25 | 79/24/16 | < 0.001 |
Neoadjuvant chemotherapy | ||||
Yes/No/unknown | 2/140/15 | 1/35/2 | 1/105/13 | 0.444 |
Adjuvant chemotherapy | ||||
Yes/No/unknown | 52/87/18 | 23/10/5 | 29/77/13 | < 0.001 |